ArticleDiabetes, obesity & metabolism2016

Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.

M A Boustani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.